Cointime

Cadence Pharmaceuticals

company

About

Cadence Pharmaceuticals is a manufactures of medicines , especially pain management solutions.

  • 251 - 500

Highlights

Total Funding Amount
$86.60M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$86.60M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2004
Number Of Employee
251 - 500
Operating Status
Active

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 2010 Cadence resubmitted a New Drug Application for its investigational product candidate, OFIRMEVTM (acetaminophen) injection for the treatment of pain and fever in adults and children. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date for OFIRMEV of November 4, 2010.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$86.60M
Cadence Pharmaceuticals has raised a total of $86.60M in funding over 2 rounds. Their latest funding was raised on Feb 23, 2009 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 23, 2009 Post-IPO Equity $86.60M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Cadence Pharmaceuticals is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures — Post-IPO Equity
Cointime
Содержание
компания